3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Glioblastoma
37
Glioma
19
Brain Neoplasms
12
Gliosarcoma
10
Astrocytoma
10
Neuroblastoma
9
Sarcoma, Ewing
8
Rhabdomyosarcoma
7
Neoplasms
7
Recurrence
6
Sarcoma
5
Oligodendroglioma
5
Small Cell Lung Carcinoma
3
Osteosarcoma
3
Neoplasm Metastasis
3
Medulloblastoma
3
Diffuse Intrinsic Pontine Glioma
3
Wilms Tumor
2
Pancreatic Neoplasms
2
Melanoma
2
Lymphoma, Follicular
2
Hepatoblastoma
2
Colorectal Neoplasms
2
Central Nervous System Neoplasms
2
Spinal Cord Neoplasms
1
Somatostatinoma
1
Rhabdoid Tumor
1
Refractory Solid Tumors
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Interventions
gallium Ga 68 dotatate
1
Temozolomide
1
Standard of Care
1
Radiotherapy
1
Nivolumab
1
Eflornithine
1
Drug Therapy
1
CLR1404
1
Blood Specimen Collection
1
Automobiles
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Temozolomide
×
90 days
×
Clear all
NCT06861244
2026-04-23
PNOC031
University of California, San Francisco
Phase 2
Recruiting
70 enrolled